VIEMED HEALTHCARE, INC.
Data quality: 100%
VMD
NASDAQ
Services
Health Services
$9.51
▲
$0.02
(0.21%)
Mkt Cap: 371.36 M
Price
$9.62
Mkt Cap
371.36 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 23.27% annually over 5 years — strong growth
Earnings grew 32.57% over the past year
ROE of 10.93% — decent returns on equity
Debt/Equity of 0.15 — conservative balance sheet
Generating 11.93 M in free cash flow
Growth
Revenue Growth (5Y)
23.27%
Above sector avg (4.21%)
Revenue (1Y)20.52%
Earnings (1Y)32.57%
FCF Growth (3Y)-21.00%
Quality
Return on Equity
10.93%
Above sector avg (-15.99%)
ROIC10.61%
Net Margin5.53%
Op. Margin8.49%
Safety
Debt / Equity
0.15
Below sector avg (0.38)
Current Ratio1.13
Interest CoverageN/A
Valuation
PE (TTM|NTM|2027)
24.87 | 15.34 | 15.52
Above sector avg (-1.17)
P/B Ratio2.78
EV/EBITDA7.37
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (515 peers)
Peer Comparison
vs Services sector median (515 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 24.9 | -1.2 |
| P/B | 2.8 | 1.4 |
| ROE % | 10.9 | -16.0 |
| Net Margin % | 5.5 | -19.4 |
| Rev Growth 5Y % | 23.3 | 4.2 |
| D/E | 0.2 | 0.4 |
Analyst Price Target
2 analysts
Hold
Current
$9.51
Target
$13.00
$11.00
$13.00
$15.00
Forecast
Forward P/E
15.34
Forward EPS
$0.62
EPS Growth (est.)
+29.2%
Est. Revenue
362.70 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.62
$0.60 – $0.64
|
362.70 M | 2 |
| FY2026 |
$0.48
$0.46 – $0.50
|
315.45 M | 2 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
$0.12
$0.11 – $0.13
|
77.75 M | 2 |
| 2026 Q1 |
$0.09
$0.09 – $0.09
|
74.40 M | 2 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | $0.13 | $0.14 | +12.0% |
| Q32025 | $0.09 | $0.09 | 0.0% |
| Q22025 | $0.09 | $0.08 | -11.1% |
| Q12025 | $0.06 | $0.06 | 0.0% |
ETFs Holding This Stock
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.52% | Revenue Growth (3Y) | 21.53% |
| Earnings Growth (1Y) | 32.57% | Earnings Growth (3Y) | 20.75% |
| Revenue Growth (5Y) | 23.27% | Earnings Growth (5Y) | 13.10% |
| Profitability | |||
| Revenue (TTM) | 270.28 M | Net Income (TTM) | 14.93 M |
| ROE | 10.93% | ROA | 7.72% |
| Gross Margin | 57.52% | Operating Margin | 8.49% |
| Net Margin | 5.53% | Free Cash Flow (TTM) | 11.93 M |
| ROIC | 10.61% | FCF Growth (3Y) | -21.00% |
| Safety | |||
| Debt / Equity | 0.15 | Current Ratio | 1.13 |
| Interest Coverage | N/A | Asset Turnover | 1.40 |
| Working Capital | 5.79 M | Tangible Book Value | 73.80 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 24.87 | Forward P/E | 15.34 |
| P/B Ratio | 2.78 | P/S Ratio | 1.37 |
| PEG Ratio | 1.90 | Forward PEG | 0.53 |
| EV/EBITDA | 7.37 | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.02 | Fwd Earnings Yield | 6.52% |
| FCF Yield | 3.21% | ||
| Market Cap | 371.36 M | Enterprise Value | 379.82 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.37 | Revenue / Share | 7.00 |
| FCF / Share | 0.31 | OCF / Share | 1.34 |
| EPS CAGR (1Y) | 32.14% | EPS CAGR (5Y) | 13.88% |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 14.79% | FCF Conversion | 79.89% |
| SBC-Adj. FCF | 3.39 M | Growth Momentum | -2.75 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 270.28 M | 224.26 M | 183.01 M | 138.83 M | 117.06 M |
| Net Income | 14.93 M | 11.27 M | 10.24 M | 6.22 M | 9.13 M |
| EPS (Diluted) | 0.37 | 0.28 | 0.25 | 0.16 | 0.22 |
| Gross Profit | 155.46 M | 133.20 M | 112.78 M | 84.68 M | 73.41 M |
| Operating Income | 22.95 M | 17.90 M | 14.33 M | 8.25 M | 11.58 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3.02 M | 3.07 M | 2.78 M | 2.70 M | 2.11 M |
| SG&A Expenses | 121.37 M | 106.20 M | 87.88 M | 68.16 M | 54.89 M |
| D&A | 28.61 M | 25.37 M | 21.86 M | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 6.39 M | 4.76 M | 4.15 M | 2.77 M | 3.38 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 199.15 M | 177.07 M | 154.90 M | 117.04 M | 117.96 M |
| Total Liabilities | 55.63 M | 43.77 M | 41.00 M | 19.95 M | 23.14 M |
| Shareholders' Equity | 141.55 M | 131.39 M | 113.90 M | 97.09 M | 94.82 M |
| Total Debt | 11.29 M | 3.59 M | 6.00 M | 0.0 | 4.31 M |
| Cash & Equivalents | 13.50 M | 17.54 M | 12.84 M | 16.91 M | 28.41 M |
| Current Assets | 48.49 M | 52.88 M | 38.37 M | 39.74 M | 47.31 M |
| Current Liabilities | 41.06 M | 37.33 M | 32.12 M | 18.86 M | 17.81 M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth
Full Throttle
#20 of 21
Recent Activity
Entered
Full Throttle
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"VMD","listing_kind":"stock","pathname":"/stocks/vmd","exchange":"NASDAQ","country":"US"}}